Overview
  • Recommended for the vaccination of healthy dogs 6 weeks of age and older for prevention of disease due to canine distemper, adenovirus type 2, parainfluenza and parvovirus live virus
  • Contains a lyophilized suspension of recombinant canarypox vector expressing HA and F glycoproteins of canine distemper virus, modified live adenovirus type 2, parainfluenza virus and parvovirus
  • Subcutaneous or Intramuscular injection